Protein that mimics exercise effects may treat heart failure

Image
Press Trust of India Toronto
Last Updated : Aug 09 2017 | 5:42 PM IST
Scientists have identified a protein that can trick the heart into growing in a healthy way and boost blood flow by mimicking the effects of exercise, an advance that may help treat heart failure patients.
Researchers, including those from University of Ottawa in Canada, discovered that a protein called cardiotrophin 1 (CT1) can trick the heart into pumping more blood, just as it does in response to exercise and pregnancy.
They showed that this good kind of heart growth is very different from the harmful enlargement of the heart that occurs during heart failure.
The team also found that CT1 can repair heart damage and improve blood flow in animal models of heart failure.
Heart failure is a leading cause of death and disability in high-income countries and a growing problem around the world.
It occurs when the heart can not pump enough blood through the body, often because a heart attack has damaged the heart muscle tissue.
"When part of the heart dies, the remaining muscles try to adapt by getting bigger, but this happens in a dysfunctional way and it does not actually help the heart pump more blood," said Lynn Megeney, professor at the University of Ottawa.
"We found that CT1 causes heart muscles to grow in a more healthy way and it also stimulates blood vessel growth in the heart. This actually increases the heart's ability to pump blood, just like what you would see with exercise and pregnancy," Megeney said.
Researchers conducted a variety of studies in mice, rats and cells growing in the lab. In addition to CT-1, some of the studies involved a drug called phenylephrine (PE), which is known to cause the bad kind of heart growth.
"This experimental therapy is very exciting, particularly because it shows promise in treating both left and right heart failure," said Duncan Stewart, a professor at the University of Ottawa.
"Currently, the only treatment for right heart failure is a transplant. And although we have drugs that can reduce the symptoms of left heart failure, we can not fix the problem, and left heart failure often leads to right heart failure over time," Stewart said.
The study was published in the journal Cell Research.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 09 2017 | 5:42 PM IST

Next Story